banner

Stock Chart Videos back to homepage

Kraig Biocraft Laboratories Stock Chart Analysis Video Kraig Biocraft Laboratories Stock Chart Analysis Video(0)

The Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) chart has some solid support levels established at 9 and 10 cents. The indicators are showing decent strength to trend and momentum as the moving averages are well-positioned. Technical traders will be looking for a break of resistance at 12 cents.

Kraig released news yesterday as we discussed in an article regarding a new licensing agreement with the University of Notre Dame.  While this video is only a technical look at the KBLB stock chart, this is an interesting company with a product that could potentially revolutionize the textile industry.  Due diligence is encouraged.



KBLB Stock Chart Technical Analysis Video:

Kraig Biocraft Labs (KBLB) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

IntelGenx Stock Chart Analysis Video IntelGenx Stock Chart Analysis Video(0)

A “stock to watch” this week, IntelGenx has had two great days so far. Momentum has gripped the stock with volume surging, keeping it on radar to possibly test resistance around 90 cents.


IntelGenx has been the focus of several articles across the web recently as it is slated for an FDA decision this month. Attention is coming to the play with volume steadily increasing in the first days of November bringing a sharp rise in share value.


IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx’ research and development pipeline includes products for the treatment of severe depression, hypertension, erectile dysfunction, benign prostatic hyperplasia, migraine, insomnia, bipolar disorder, idiopathic pulmonary fibrosis, allergies and pain management. More information is available about the company at www.intelgenx.com.

IntelGenx Corp. (IGXT) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Bulova Technologies Group Stock Chart Analysis Video Bulova Technologies Group Stock Chart Analysis Video(0)

The Bulova Technologies’ (Pink Sheets:BLVT) chart is forming a bottom and gaining momentum. Support is set at a penny with a significant upside to resistance to $0.016 and then not again until the 3 cent mark. Technical traders will be watching for volume to try and continue the trend shift towards bullishness.




Bulova Technologies Group, Inc. and Bulova Technologies Europe LLC are headquartered in Clearwater, Florida. Bulova Technologies Group, Inc. is registered with the United States Department of State Directorate of Defense Trade Controls (DDTC) as a broker.

Bulova Technologies Ordnance Systems LLC is located on 261 acres in Mayo, Florida, and is a load, assemble, and pack (L.A.P.) facility specializing in fuzes, safe and arming devices and explosive simulators.

Bulova Technologies Group (BLVT) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

TapImmune Stock Chart Analysis Video TapImmune Stock Chart Analysis Video(0)

Looking to come off the bottom, the TapImmune Inc. (OTCBB:TPIV) chart had a volume surge on Friday and closed green for the day. The PPS has pushed back up to grab support at 15 and 16 cents with technical traders looking for volume to continue to push the chart back towards resistance at 21 cents.




TapImmune’s unique approach is designed to increase the efficacy of vaccines by enhancing antigen presentation through the use of the Transporter of Antigen Processing (‘TAP’). Replacement of this transporter provides a significant immune response with the potential to treat a variety of cancers which lack normal amounts of TAP. TapImmune’s lead product candidate, AdhTAP, is designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system. The Company is currently planning the development of AdhTAP for the commencement of clinical manufacturing and toxicology studies. As a stand-alone cancer therapy or in combination with other drugs, AdhTAP could prove to be a key component of a more successful assault on cancer. TapImmune is initiating clinical development of a multi-component vaccine for the treatment of HER-2/neu positive breast cancer.

The Company is also developing a TAP-based prophylactic vaccine which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by up to 1000 times. TapImmune’s TAP technology could significantly improve the efficacy of many current prophylactic vaccines and enhance the creation of new ones in the fight against many pandemic infectious diseases. A next generation smallpox vaccine is currently in preclinical development.

More information can be found at www.tapimmune.com.

TapImmune Inc. (TPIV) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Brekford Int’l Corp. Stock Chart Analysis Video Brekford Int’l Corp. Stock Chart Analysis Video(0)

Brekford has been on a strong climb since April 2011 with shares moving from a dime to nearly 60 cents each.  A consolidation is happening with support at 40 cents and a blue sky breakout at 59 cents.  Technical traders will be watching for volume to pick-up on this low-float chart to see if the channel will be broken.

Brekford recently announced a 38% increase in revenue, 117% increase in gross profit, and an increase in net profit of 3,685% for second fiscal quarter 2011.




For over a decade, Brekford has been providing services to the U.S. military, various federal entities and numerous security and public safety agencies throughout the United States with an end-to-end suite of mobile computer and video technology, vehicle upfitting services, and automated traffic safety solutions. Brekford is a one-stop shop with its unique 360-degree approach to vehicle upfitting services, cutting edge mobile and video technology, and automated traffic enforcement services for homeland security and law enforcement agencies. Additional information about Brekford may be found online at www.brekford.com.

Brekford International Corp. (BFDI) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

China New Borun Corp. Stock Chart Video Analysis China New Borun Corp. Stock Chart Video Analysis(0)

Despite a sharp slide over the last week, BORN is hitting the watchlist for a potential bounce. With the drop in value, resistance is more than 15 percent away with a close, short-term support level.

Kapitall recently contributed an article to Seeking Alpha which included their analysis on several stocks, including China New Borun:  17 Undervalued Smart Money Picks Trading Under $5.




China New Borun Corporation is a leading producer and distributor of corn-based edible alcohol in China.  Borun’s edible alcohol products are primarily sold as an ingredient to producers of baijiu, a popular grain-based alcoholic beverage that is sold throughout China in retail stores, restaurants and bars. The Company also produces DDGS Feed, Corn Germ, liquid carbon dioxide and crude corn oil as by-products of edible alcohol production.  China New Borun is based in Shouguang, Shandong Province.  Additional information about the company can be found at http://www.chinanewborun.com.

China New Borun Corp. (BORN) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Presstek Stock Chart Analysis Video Presstek Stock Chart Analysis Video(0)

Two straight green days has the Presstek chart looking to reverse course since its fall from over $1. Short-term support is set at 70 cents with resistance in front at $0.80, but then not again until $0.88 and $1.00.




Presstek, Inc. is a leading supplier of digital offset printing solutions to the printing and communications industries. Presstek’s DI® digital offset solutions bridge the gap between toner and conventional offset printing, enabling printers to cost effectively meet increasing customer demand for high quality, short run color printing with a fast turnaround time while providing improved profit margins. The company’s CTP portfolio ranges from two-page to eight-page systems, many of which are fully automated. These systems support Presstek’s line of chemistry-free plates as well as Aeon, a no preheat thermal plate which offers run lengths up to one million impressions. Presstek also offers a range of workflow solutions, pressroom supplies, and reliable service. Presstek is well positioned to support print environments of any size on a worldwide basis. For more information visit www.presstek.com or send an e-mail to [email protected].

Presstek (PRST) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Ecosphere Technologies Stock Chart Analysis Video Ecosphere Technologies Stock Chart Analysis Video(0)

The ESPH chart has given a number of head fakes in the past towards making a stronger upward move, but has put together three straight green days recently which will have traders taking a closer look at the chart again. The indicators are showing a strong trend a good momentum, which adds credence to the possibility of a stronger move to take out resistance at 52 cents.

The Company had news this morning which we briefly discussed in our article on its new orders and growing revenue stream.




Ecosphere Technologies, Inc. is a diversified water engineering, technology licensing and environmental services company that designs, develops and manufactures wastewater treatment solutions for industrial markets. The Company provides environmental services and technologies for use in large-scale and sustainable applications across industries, nations and ecosystems. Ecosphere is driving clean water innovation with its patented Ozonix advanced oxidation technologies and its mobile, low maintenance water treatment systems. Ecosphere’s patented Ozonix Technology is a high volume, advanced oxidation process designed to recycle water while reducing liquid chemicals used during water treatment applications. More information can be found at www.EcosphereTech.com.

Ecosphere Technologies (ESPH) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

China Wi-Max Communications Stock Chart Analysis Video China Wi-Max Communications Stock Chart Analysis Video(0)

Shares of China Wi-Max Communications (OTCBB:CHWM) have risen by 20 percent with strong volume in the last two days, trading 3.7 million shares yesterday. The chart now faces resistance at $0.006 (yesterday’s closing price). The next level of resistance is not until $0.008 and support stands at $0.005. A classic bottom play with MACD/PPS positive divergence, technical traders will be watching for volume to remain strong to show that CHWM may have found a true bottom.



The Company released news this morning announcing the signing of two strategic business agreements to utilize its fiber assets and wireless frequencies and has the potential to generate significant revenue streams in the future. One of the agreements was with China CTV Television Network Center to develop nationwide fiber optical networks for delivering Digital TV and other value added services throughout China. The second was with the premier IPTV technology and content provider, 3Screen Group Ltd, Hong Kong, United Kingdom, inclusive with their partner DigiSoft.tv Ltd. Ireland. Together, through CHWM, they will deliver a complete IPTV solution to CTVN’s extensive subscriber market in China.

China Wi-Max Communications, Inc. is a multinational telecommunications and IP transport company formed to take advantage of the rapidly expanding wireless and broadband communications needs in China and elsewhere. The goal of CHWM is to become the premier provider of broadband technology and allied services in the Chinese market and beyond. Building on technical experience and proven management skills, CHWM is approaching its markets with the tools and experience necessary to achieve success. CHWM has acquired fiber assets in Beijing and Hangzhou, as well as option agreements to purchase fiber in Shanghai and seven additional cities in China. CWHM has also acquired 5.8 GHz wireless frequencies. More information can be found at the Company’s website at www.chinawi-max.com.

China Wi-Max Communications (CHWM) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

247MGI, Inc. Stock Chart Video Analysis 247MGI, Inc. Stock Chart Video Analysis(0)

Rising from $0.0007 to $0.0017 recently, the 247MGI, Inc. (Pink Sheets:TOFS) chart is starting to maintain momentum on heavy volume as the MACD looks to be changing its course of trend.  Technical and momentum traders will be watching the chart now for continuation with an upper-end resistance at $0.0024.

247MGI has been restructuring (reducing debt, lowering authorized shares, filing all required paperwork) and moving close to its previously announced merger with a private company in a multi-billion dollar industry.  Recent news showed that all necessary documentation has been filed with OTCMarkets for TOFS to now be listed as “OTC Pink.”



247MGI, Inc. (TOFS) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.